Cellomics Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $49M

Cellomics General Information

Description

Developer and marketer of high content screening systems. The company develops and markets high content screening systems for drug screening and localization within living cells. The company's core expertise included Quantitative Fluorescence Microscopy, Cell Biology, Molecular Biology, Drug Discovery and Pharmacology, Engineering, Applied Optics and physics, Database Design and Data Mining.

Contact Information

Website
www.cellomics.com
Formerly Known As
BioDx
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 100 Technology Drive
  • Pittsburgh, PA 15219
  • United States
+1 (412) 000-0000
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Healthcare Technology Systems
Drug Discovery
Acquirer
Thermo Fisher Scientific
Vertical(s)
TMT, Life Sciences
Corporate Office
  • 100 Technology Drive
  • Pittsburgh, PA 15219
  • United States
+1 (412) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 01-Jan-2005 $49M 000.00 0000 Completed Generating Revenue
7. Later Stage VC (Series AAA) 02-Dec-2003 000.00 000.00 Completed Generating Revenue
6. Later Stage VC 02-Dec-2003 00000 000.00 Completed Generating Revenue
5. Debt - General 12-Sep-2002 0000 000.00 Completed
4. Later Stage VC 30-Aug-2002 00.000 000.00 Completed Generating Revenue
3. IPO 30-Oct-2001 0000 Cancelled
2. Early Stage VC (Series B) 01-Feb-2000 $6.53M $16.8M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-1999 $10.3M $10.3M 0000 Completed Product Development
To view Cellomics’s complete valuation and funding history, request access »

Cellomics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 000,000 00.000000 000.00 000.00 000.00 0.000
Series A 0,000,000 00.000000 00.00 00.00 00.00 00.000
To view Cellomics’s complete cap table history, request access »

Cellomics Patents

  • 282

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 110

    Granted

  • 11

    Pending

  • 000

    Expiring in next 12 mo

Cellomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220120664-A1 Systems and methods for autofocus and automated cell count using artificial intelligence Pending 16-Oct-2020 00000000
EP-4229460-A2 Systems and methods for autofocus and automated cell count using artificial intelligence Pending 16-Oct-2020 00000000
US-20170276857-A1 Optic homogenizer Active 16-Dec-2014 000000000 0
US-10353130-B2 Optic homogenizer Active 16-Dec-2014 0000000000 00
EP-3234455-A1 Optic homogenizer Active 16-Dec-2014 G02B6/0008
To view Cellomics’s complete patent history, request access »

Cellomics Executive Team (5)

Name Title Board Seat
Andy Liu Chief Executive Officer
You’re viewing 1 of 5 executive team members. Get the full list »

Cellomics Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alta Partners Venture Capital Minority 000 0000 000000 0
Axiom Venture Partners Venture Capital Minority 000 0000 000000 0
Burrill & Co Merchant Banking Firm Minority 000 0000 000000 0
Delphi Ventures Venture Capital Minority 000 0000 000000 0
InterWest Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Cellomics FAQs

  • When was Cellomics founded?

    Cellomics was founded in 1996.

  • Who is the CEO of Cellomics?

    Andy Liu is the CEO of Cellomics.

  • Where is Cellomics headquartered?

    Cellomics is headquartered in Pittsburgh, PA.

  • What industry is Cellomics in?

    Cellomics’s primary industry is Enterprise Systems (Healthcare).

  • Is Cellomics a private or public company?

    Cellomics is a Private company.

  • What is the current valuation of Cellomics?

    The current valuation of Cellomics is 0000.

  • What is Cellomics’s current revenue?

    The current revenue for Cellomics is 00000.

  • How much funding has Cellomics raised over time?

    Cellomics has raised $66.6M.

  • Who are Cellomics’s investors?

    Alta Partners, Axiom Venture Partners, Burrill & Co, Delphi Ventures, and InterWest Partners are 5 of 8 investors who have invested in Cellomics.

  • When was Cellomics acquired?

    Cellomics was acquired on 01-Jan-2005.

  • Who acquired Cellomics?

    Cellomics was acquired by Thermo Fisher Scientific.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »